Wright Medical Planning Lineage Ceramic-On-Ceramic Hip Launch In Q4
This article was originally published in The Gray Sheet
Executive Summary
Wright Medical and Stryker Howmedica Osteonics are both awaiting ceramic material supplier GMP certification prior to final FDA approval for their respective Lineage and Trident ceramic-on-ceramic hip prostheses, expected in late 2002
You may also be interested in...
Ceramic-Bearing Hip Surfaces Receive FDA Approval Following GMP Delay
Stryker Howmedica Osteonics and Wright Medical are set to introduce their Trident and Transcend ceramic-on-ceramic hip implants, respectively, in the U.S. following simultaneous PMA approvals Feb. 3
Ceramic-Bearing Hip Surfaces Receive FDA Approval Following GMP Delay
Stryker Howmedica Osteonics and Wright Medical are set to introduce their Trident and Transcend ceramic-on-ceramic hip implants, respectively, in the U.S. following simultaneous PMA approvals Feb. 3
Wright Medical Enters Injectable BVF Market, Joining J&J/DePuy, Synthes
Wright Medical Group will market its MIIG 115 minimally invasive injectable Osteoset bone graft substitute system primarily to trauma surgeons supported by a sales force of 220 commissioned reps in the U.S